MedPath

The AFRICA-FINGERS Project

Not Applicable
Conditions
Mental and Behavioural Disorders
Registration Number
PACTR202407499314703
Lead Sponsor
Aga Khan University kenya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
600
Inclusion Criteria

1. Age 50 – 85 years.
2. CAIDE Dementia Risk Score =6 points (based on age, sex, education, systolic blood pressure, BMI, total cholesterol, and physical activity; range 0–14 points). The CAIDE risk score will be calculated based on data already collected as part of the relevant register or newly collected as part of the screening for lifestyle process.
3. Cognitive performance at the mean level or slightly lower than expected for age according to local population norms. The aim of this screening for lifestyle is to exclude individuals with substantial cognitive impairment/dementia, but also high performers, with low likelihood of change over 24 months. The cognitive screening for lifestyle will be based on the IDEA test.
4. Proficiency in the local language i.e. fluency and literacy in English and/or major traditional dialect Swahili (Kiswahili), Igbo or Yoruba
5. Able to consent
6. Any medication affecting cognition must have a stable dose for =4 weeks.

Exclusion Criteria

1. Dementia or substantial cognitive impairment (e.g., memory clinic referral needed as judged by the study physician). IDEA-IADL score =10), or high functioning level (IDEA > age-adjusted 70th centile
2. Current or past use of medications for AD or related diseases (e.g., cholinesterase inhibitors, memantine).
3. Diminished decision-making capacity, not capable of consenting or completing study assessments, based on clinical judgement.
4. Other known significant neurologic disease, including but not limited to Parkinson’s disease, Huntington’s disease, normal pressure hydrocephalus, brain tumor, progressive, supranuclear palsy, seizure disorder, subdural hematoma, multiple sclerosis, or history of significant head trauma with persistent neurologic sequelae or known structural brain abnormalities.
5. Any other condition affecting safe engagement in the intervention, e.g. malignant disease, major depression, symptomatic cardiovascular disease, revascularization within the previous year.
6. Severe loss of vision, hearing, or communicative ability; conditions preventing cooperation as judged by the study physician.
7. Coincident participation in the active phase of another intervention trial.
8. Severe health conditions/recent surgical or other major procedures preventing safe intervention engagement/ trial participation as judged by study physician (e.g., severe sensory impairment; on-going major psychiatric illness)

Exclusion criteria affecting the engagement in the intervention will be evaluated by the study physician for those meeting the cognitive inclusion criteria. Internet literacy will be also evaluated to ensure that each participant is willing to engage with the remote components of the intervention.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
europsychological performance measures using the modified Neuropsychological Test Battery composite z score. The Composite score will be an average of the three composite cognitive domain scores of the executive function, processing speed, and memory subtests.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath